A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen
Clinical trial NCT00615056 · COMPLETED
Trial details
- NCT number
- NCT00615056
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2011-03-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.